Literature DB >> 30831571

Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.

Sanela Slavković1, Milica Lazić2, Cynthia Honan3, Čongor Nađ4, Nina Brkić-Jovanović5, Špela Golubović6.   

Abstract

OBJECTIVE: The purpose of this study was to ascertain whether the application of the Audio Recorded Cognitive Screen (ARCS) in cognitive functioning screening of persons with multiple sclerosis (MS) differentiates profiles of existing cognitive deficits (CDs) and whether this instrument can discriminate accurately between subjects who are cognitively intact (CI) and those with a cognitive disorder. SUBJECTS AND METHODS: The research was conducted on a sample of 359 subjects, with two subsets of participants: 108 persons with a relapsing-remitting form of MS and 251 persons from the general population.
RESULTS: We labeled the three profiles obtained by applying the ARCS questionnaire: the CI profile, the profile of CI with visuospatial difficulties, and the profile of persons with CD.
CONCLUSION: ARCS has the ability to differentiate persons with a CD from those without, both in a sample of persons suffering from MS and in a sample of persons from the general population. This finding indicates that this instrument is well suited for profiling the cognitive status into specific categories, which puts it among the instruments with a wide range of implementation.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive ability; Diagnostic; Multiple sclerosis; Prognosis

Mesh:

Year:  2019        PMID: 30831571      PMCID: PMC6639583          DOI: 10.1159/000499312

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  22 in total

Review 1.  Clock-drawing: is it the ideal cognitive screening test?

Authors:  K I Shulman
Journal:  Int J Geriatr Psychiatry       Date:  2000-06       Impact factor: 3.485

2.  Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis.

Authors:  Françoise Reuter; Wafaa Zaaraoui; Lydie Crespy; Anthony Faivre; Audrey Rico; Irina Malikova; Elisabeth Soulier; Patrick Viout; Jean-Philippe Ranjeva; Jean Pelletier; Bertrand Audoin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-22       Impact factor: 10.154

3.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

4.  Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.

Authors:  Marco Pitteri; Chiara Romualdi; Roberta Magliozzi; Salvatore Monaco; Massimiliano Calabrese
Journal:  Mult Scler       Date:  2016-08-15       Impact factor: 6.312

5.  Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.

Authors:  S C J Huijbregts; N F Kalkers; L M J de Sonneville; V de Groot; I E W Reuling; C H Polman
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

Review 6.  Cognitive changes in multiple sclerosis.

Authors:  Maria Pia Amato; Valentina Zipoli; Emilio Portaccio
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

7.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.

Authors:  Mariana López-Góngora; Luis Querol; Antonio Escartín
Journal:  BMC Neurol       Date:  2015-03-22       Impact factor: 2.474

10.  Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.

Authors:  Domenica Nunnari; Maria Cristina De Cola; Giangaetano D'Aleo; Carmela Rifici; Margherita Russo; Edoardo Sessa; Placido Bramanti; Silvia Marino
Journal:  Biomed Res Int       Date:  2015-03-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.